Research Article
Prognostic Impact of mRNA Expression Levels of HER1–4 (ERBB1–4) in Patients with Locally Advanced Rectal Cancer
Table 2
Patients’ characteristics.
| | Neoadjuvant treatment | Adjuvant treatment |
| (patients) | 30 | 56 |
| Age (years), median range | 67 47–83 | 62 44–75 |
| Gender, (%) | | | Male | 20 (67) | 36 (64) | Female | 10 (33) | 20 (36) |
| 5-Fluorouracil, (%) | 15 (50) | 27 (48) |
| Capecitabine, (%) | 15 (50) | 29 (52) |
| Recurrence during follow-up, (%) | | | Local recurrence | 1 () | 3 () | Metastasis | 9 (30) | 15 (27) |
|
|